Logo image of S30.PA

SOLUTIONS 30 SE (S30.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:S30 - FR0013379484 - Common Stock

0.949 EUR
-0.01 (-1.25%)
Last: 12/2/2025, 10:25:23 AM
Fundamental Rating

2

Overall S30 gets a fundamental rating of 2 out of 10. We evaluated S30 against 72 industry peers in the IT Services industry. S30 has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, S30 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year S30 has reported negative net income.
S30 had a positive operating cash flow in the past year.
In multiple years S30 reported negative net income over the last 5 years.
S30 had a positive operating cash flow in each of the past 5 years.
S30.PA Yearly Net Income VS EBIT VS OCF VS FCFS30.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

The Return On Assets of S30 (-3.81%) is worse than 77.78% of its industry peers.
Looking at the Return On Equity, with a value of -35.89%, S30 is doing worse than 81.94% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 2.18%, S30 is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA -3.81%
ROE -35.89%
ROIC 2.18%
ROA(3y)-4.19%
ROA(5y)-0.94%
ROE(3y)-25.27%
ROE(5y)-8.32%
ROIC(3y)N/A
ROIC(5y)N/A
S30.PA Yearly ROA, ROE, ROICS30.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

Looking at the Operating Margin, with a value of 0.79%, S30 is doing worse than 77.78% of the companies in the same industry.
S30's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 90.31%, S30 belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
In the last couple of years the Gross Margin of S30 has remained more or less at the same level.
Industry RankSector Rank
OM 0.79%
PM (TTM) N/A
GM 90.31%
OM growth 3Y-22.42%
OM growth 5Y-25.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.4%
S30.PA Yearly Profit, Operating, Gross MarginsS30.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1

2. Health

2.1 Basic Checks

S30 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
S30 has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for S30 remains at a similar level compared to 5 years ago.
The debt/assets ratio for S30 has been reduced compared to a year ago.
S30.PA Yearly Shares OutstandingS30.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
S30.PA Yearly Total Debt VS Total AssetsS30.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

S30 has an Altman-Z score of 1.53. This is a bad value and indicates that S30 is not financially healthy and even has some risk of bankruptcy.
S30 has a worse Altman-Z score (1.53) than 75.00% of its industry peers.
The Debt to FCF ratio of S30 is 10.48, which is on the high side as it means it would take S30, 10.48 years of fcf income to pay off all of its debts.
S30 has a Debt to FCF ratio of 10.48. This is in the lower half of the industry: S30 underperforms 72.22% of its industry peers.
S30 has a Debt/Equity ratio of 1.67. This is a high value indicating a heavy dependency on external financing.
S30's Debt to Equity ratio of 1.67 is on the low side compared to the rest of the industry. S30 is outperformed by 80.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 10.48
Altman-Z 1.53
ROIC/WACC0.35
WACC6.16%
S30.PA Yearly LT Debt VS Equity VS FCFS30.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

S30 has a Current Ratio of 0.95. This is a bad value and indicates that S30 is not financially healthy enough and could expect problems in meeting its short term obligations.
S30's Current ratio of 0.95 is on the low side compared to the rest of the industry. S30 is outperformed by 72.22% of its industry peers.
A Quick Ratio of 0.90 indicates that S30 may have some problems paying its short term obligations.
The Quick ratio of S30 (0.90) is worse than 70.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.9
S30.PA Yearly Current Assets VS Current LiabilitesS30.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for S30 have decreased strongly by -87.74% in the last year.
The Revenue for S30 has decreased by -10.35% in the past year. This is quite bad
The Revenue has been growing slightly by 7.57% on average over the past years.
EPS 1Y (TTM)-87.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-185.45%
Revenue 1Y (TTM)-10.35%
Revenue growth 3Y4.45%
Revenue growth 5Y7.57%
Sales Q2Q%-9.66%

3.2 Future

The Earnings Per Share is expected to grow by 50.70% on average over the next years. This is a very strong growth
Based on estimates for the next years, S30 will show a quite strong growth in Revenue. The Revenue will grow by 9.22% on average per year.
EPS Next Y-268.89%
EPS Next 2Y-33.33%
EPS Next 3Y50.7%
EPS Next 5YN/A
Revenue Next Year-4.87%
Revenue Next 2Y1.62%
Revenue Next 3Y4.39%
Revenue Next 5Y9.22%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
S30.PA Yearly Revenue VS EstimatesS30.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
S30.PA Yearly EPS VS EstimatesS30.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for S30. In the last year negative earnings were reported.
Also next year S30 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
S30.PA Price Earnings VS Forward Price EarningsS30.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, S30 is valued cheaply inside the industry as 95.83% of the companies are valued more expensively.
S30's Price/Free Cash Flow ratio is rather cheap when compared to the industry. S30 is cheaper than 94.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.71
EV/EBITDA 3.24
S30.PA Per share dataS30.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

S30's earnings are expected to grow with 50.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.33%
EPS Next 3Y50.7%

0

5. Dividend

5.1 Amount

S30 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SOLUTIONS 30 SE

EPA:S30 (12/2/2025, 10:25:23 AM)

0.949

-0.01 (-1.25%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-05 2025-11-05
Earnings (Next)03-30 2026-03-30/amc
Inst Owners3.06%
Inst Owner ChangeN/A
Ins Owners16.2%
Ins Owner ChangeN/A
Market Cap101.67M
Revenue(TTM)946.00M
Net Income(TTM)-26.70M
Analysts48
Price Target1.25 (31.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.67%
PT rev (3m)-35.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-53.71%
EPS NY rev (3m)-1006.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF 5.71
P/OCF 2.95
P/B 1.37
P/tB N/A
EV/EBITDA 3.24
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)0.17
FCFY17.51%
OCF(TTM)0.32
OCFY33.93%
SpS8.83
BVpS0.69
TBVpS-0.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.81%
ROE -35.89%
ROCE 2.96%
ROIC 2.18%
ROICexc 2.84%
ROICexgc 13.35%
OM 0.79%
PM (TTM) N/A
GM 90.31%
FCFM 1.88%
ROA(3y)-4.19%
ROA(5y)-0.94%
ROE(3y)-25.27%
ROE(5y)-8.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y18.76%
ROICexgc growth 5Y4.57%
ROICexc growth 3Y-11.4%
ROICexc growth 5Y-15.36%
OM growth 3Y-22.42%
OM growth 5Y-25.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.4%
F-Score2
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 10.48
Debt/EBITDA 1.75
Cap/Depr 26.3%
Cap/Sales 1.77%
Interest Coverage 2.27
Cash Conversion 48.59%
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.9
Altman-Z 1.53
F-Score2
WACC6.16%
ROIC/WACC0.35
Cap/Depr(3y)33.48%
Cap/Depr(5y)33.85%
Cap/Sales(3y)2.09%
Cap/Sales(5y)2.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-185.45%
EPS Next Y-268.89%
EPS Next 2Y-33.33%
EPS Next 3Y50.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.35%
Revenue growth 3Y4.45%
Revenue growth 5Y7.57%
Sales Q2Q%-9.66%
Revenue Next Year-4.87%
Revenue Next 2Y1.62%
Revenue Next 3Y4.39%
Revenue Next 5Y9.22%
EBIT growth 1Y-47.65%
EBIT growth 3Y-18.97%
EBIT growth 5Y-19.92%
EBIT Next Year641.67%
EBIT Next 3Y126.8%
EBIT Next 5YN/A
FCF growth 1Y-9.76%
FCF growth 3Y12.15%
FCF growth 5Y-3.78%
OCF growth 1Y-19.17%
OCF growth 3Y6.91%
OCF growth 5Y-1.82%

SOLUTIONS 30 SE / S30.PA FAQ

What is the fundamental rating for S30 stock?

ChartMill assigns a fundamental rating of 2 / 10 to S30.PA.


What is the valuation status for S30 stock?

ChartMill assigns a valuation rating of 3 / 10 to SOLUTIONS 30 SE (S30.PA). This can be considered as Overvalued.


How profitable is SOLUTIONS 30 SE (S30.PA) stock?

SOLUTIONS 30 SE (S30.PA) has a profitability rating of 2 / 10.


Can you provide the dividend sustainability for S30 stock?

The dividend rating of SOLUTIONS 30 SE (S30.PA) is 0 / 10 and the dividend payout ratio is 0%.